Ipilimumab vs Lansoprazole
Ipilimumab vs Lansoprazole: Overview
This comparison examines the pharmacological differences between Ipilimumab and Lansoprazole.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Lansoprazole: Proton pump inhibitor.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Lansoprazole β 1.5 hours.
Chemical Properties
Molecular Formula: Lansoprazole β C16H14F3N3O2S.
Molecular Weight: Lansoprazole β 369.3620 g/mol.
Type: Ipilimumab β Antibody; Lansoprazole β Small molecule.